fbpx

Trading Update on COVID-19, Outlook 2020 Withdrawn and Suspension of Share Buyback Program

EssilorLuxottica announces that in light of the evolving COVID-19 pandemic, the Company’s outlook for 2020 published on March 6, 2020 is no longer valid.

In January and February, the company delivered solid growth, in line with its full year targets. Business conditions began deteriorating in March as the virus shifted from impacting predominantly China to entire regions of Europe and North America. During the second quarter, the Company expects revenue to further decelerate with a material impact on profitability. At present, the Company has insufficient visibility to provide an assessment of the full scope of COVID-19 impact, as the situation remains volatile.

Essilor has temporarily closed all its industrial sites in France. Production continuity is ensured thanks to the company’s worldwide network of interconnected plants and laboratories. This includes all production facilities in China, which are now back to full speed and have spare capacity. E-commerce activities are growing with no back orders.

Luxottica’s manufacturing plants have temporarily suspended their activity in Italy and other smaller locations, while they are back to normal levels in China. Stores in Europe and North America are complying with the temporary lockdown measures that local governments are putting in place, while Company’s e-commerce platforms continue to operate globally.

In the context of the COVID-19 pandemic, and with the likelihood of prolonged uncertainty, EssilorLuxottica has decided to stop the implementation of its share buyback program announced on March 17, 2020.

Since March 17, 2020, 1.55 million shares for an average price of Euro 102.54 have been repurchased.

For the full trading update press release, click HERE.

Click HERE for the press release on the suspension of the share buyback program.

Featured Posts

EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Learn More
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read more
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read more
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read more
Neurolens Newton Standard Prism versus contoured prism

Large Retrospective Study Reports Greater Symptom Relief with Neurolens Contoured Prism Technology

A real-world analysis of nearly 100,000 patients found greater improvement in headaches and visual fatigue with Neurolens compared to conventional prism.

Read more
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Learn More
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read More
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read More
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read More
Neurolens Newton Standard Prism versus contoured prism

Large Retrospective Study Reports Greater Symptom Relief with Neurolens Contoured Prism Technology

A real-world analysis of nearly 100,000 patients found greater improvement in headaches and visual fatigue with Neurolens compared to conventional prism.

Read More
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Learn More
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read more
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read more
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read more
Neurolens Newton Standard Prism versus contoured prism

Large Retrospective Study Reports Greater Symptom Relief with Neurolens Contoured Prism Technology

A real-world analysis of nearly 100,000 patients found greater improvement in headaches and visual fatigue with Neurolens compared to conventional prism.

Read more
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Learn More
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read more
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read more
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read more
Neurolens Newton Standard Prism versus contoured prism

Large Retrospective Study Reports Greater Symptom Relief with Neurolens Contoured Prism Technology

A real-world analysis of nearly 100,000 patients found greater improvement in headaches and visual fatigue with Neurolens compared to conventional prism.

Read more